Browse All

Current Filters

CLEAR FILTER x

TITLE

A Phase 1 First-in-human Study to Investigate the Safety, Tolerability and Food Effect of ABBV-CLS-7262

Author:Cho, William   Jeong, Anna   Malik, Paul   Boiser, Joey   Huang, Xiu   Rosebraugh, Matthew   

Session Name:P6: General Neurology: New Treatments  

Topic:General Neurology  

Program Number:P6.002  

Author Institution:Calico Life Sciences, South San Francisco, CA  AbbVie, North Chicago, IL  

HARBOR: ABBV-916 In Subjects With Early Alzheimer’s Disease Combined Multiple-Ascending Dose/Proof-Of-Concept Study Design

Author:Watson, David   Lynch, Shau Yu   Florian, Hana   Wang, Deli   Bachhav, Sagar   Boiser, Joey   Bannon, Anthony   Stage, Edwin   Graff, Ole   

Session Name:P7: Aging and Dementia: Therapeutics 1  

Topic:Aging and Dementia  

Program Number:P7.008  

Author Institution:Alzheimer's Research and Treatment Center, Wellington, FL  Neuroscience Clinical Development, AbbVie Inc., North Chicago, IL  Statistics, AbbVie Inc., Buffalo Grove, IL  Clinical Pharmacology, AbbVie Inc., North Chicago, IL  Pharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL  Precision Medicine, AbbVie Inc., North Chicago, IL  Discovery, AbbVie Inc., North Chicago, IL